BioCryst Pharmaceuticals Inc (BCRX)
4.21
-0.17
(-3.88%)
USD |
NASDAQ |
Apr 24, 16:00
4.23
+0.02
(+0.48%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Return Level: 4.21 for April 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 24, 2024 | 4.21 |
April 23, 2024 | 4.38 |
April 22, 2024 | 4.41 |
April 19, 2024 | 4.43 |
April 18, 2024 | 4.50 |
April 17, 2024 | 4.58 |
April 16, 2024 | 4.61 |
April 15, 2024 | 4.67 |
April 12, 2024 | 4.77 |
April 11, 2024 | 5.10 |
April 10, 2024 | 4.87 |
April 09, 2024 | 4.80 |
April 08, 2024 | 4.61 |
April 05, 2024 | 4.60 |
April 04, 2024 | 4.60 |
April 03, 2024 | 4.73 |
April 02, 2024 | 4.69 |
April 01, 2024 | 5.05 |
March 28, 2024 | 5.08 |
March 27, 2024 | 5.15 |
March 26, 2024 | 5.01 |
March 25, 2024 | 4.91 |
March 22, 2024 | 5.01 |
March 21, 2024 | 5.49 |
March 20, 2024 | 5.47 |
Date | Value |
---|---|
March 19, 2024 | 5.36 |
March 18, 2024 | 5.07 |
March 15, 2024 | 5.00 |
March 14, 2024 | 4.89 |
March 13, 2024 | 5.14 |
March 12, 2024 | 5.14 |
March 11, 2024 | 5.32 |
March 08, 2024 | 5.43 |
March 07, 2024 | 5.18 |
March 06, 2024 | 5.21 |
March 05, 2024 | 5.41 |
March 04, 2024 | 5.51 |
March 01, 2024 | 5.62 |
February 29, 2024 | 5.63 |
February 28, 2024 | 5.71 |
February 27, 2024 | 5.87 |
February 26, 2024 | 5.79 |
February 23, 2024 | 5.71 |
February 22, 2024 | 5.82 |
February 21, 2024 | 5.65 |
February 20, 2024 | 5.82 |
February 16, 2024 | 5.92 |
February 15, 2024 | 5.64 |
February 14, 2024 | 5.57 |
February 13, 2024 | 5.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.585
Minimum
Nov 14 2019
19.76
Maximum
Feb 16 2022
8.376
Average
7.61
Median
May 13 2019
Total Return Level Benchmarks
AIM ImmunoTech Inc | 0.43 |
Perspective Therapeutics Inc | 1.69 |
Protalix BioTherapeutics Inc | 1.21 |
Electromed Inc | 16.73 |
Armata Pharmaceuticals Inc | 2.50 |